Recent developments in the management of severe asthma

被引：2

作者：

Meteran, Howraman ^{[1
,2
,3
]}

Tonnesen, Louise Lindhardt ^{[1
,4
]}

Sivapalan, Pradeesh ^{[1
,5
]}

Ingebrigtsen, Truls Sylvan ^{[1
]}

Jensen, Jens-Ulrik Staehr ^{[1
,6
]}

机构：

[1] Copenhagen Univ Hosp Herlev & Gentofte, Resp Med Sect, Dept Internal Med, Hellerup, Denmark

[2] Univ Copenhagen, Dept Immunol & Microbiol, Copenhagen, Denmark

[3] Aarhus Univ, Dept Publ Hlth Environm Work & Hlth, Aarhus, Denmark

[4] Copenhagen Univ Hosp, Dept Resp Med, Hvidovre, Denmark

[5] Univ Copenhagen, Zealand Hosp, Dept Internal Med, Roskilde, Denmark

[6] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark

来源：

BREATHE | 2022年 / 18卷 / 01期

关键词：

EOSINOPHILIC ASTHMA; DOUBLE-BLIND; FEVIPIPRANT; ANTAGONIST;

D O I：

10.1183/20734735.0178-2021

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页数：6

共 32 条

[1] Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCA
Albers, Frank C.
Papi, Alberto
Taille, Camille
Bratton, Daniel J.
Bradford, Eric S.
Yancey, Steven W.
Kwon, Namhee
[J]. RESPIRATORY RESEARCH, 2019, 20 (1)
[2] Severe asthma among adults: Prevalence and clinical characteristics
Backman, Helena
Jansson, Sven-Arne
Stridsman, Caroline
Eriksson, Berne
Hedman, Linnea
Eklund, Britt-Marie
Sandstrom, Thomas
Lindberg, Anne
Lundback, Bo
Ronmark, Eva
[J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
[3] Fevipiprant, an oral prostaglandin DP2 receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroids
Bateman, Eric D.
Guerreros, Alfredo G.
Brockhaus, Florian
Holzhauer, Bjorn
Pethe, Abhijit
Kay, Richard A.
Townley, Robert G.
[J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (02)
[4] FeNO-based asthma management results in faster improvement of airway hyperresponsiveness
Bernholm, Katrine Feldballe
Homoe, Anne-Sophie
Meteran, Howraman
Jensen, Camilla Bjorn
Porsbjerg, Celeste
Backer, Vibeke
[J]. ERJ OPEN RESEARCH, 2018, 4 (04)
[5] Thymic Stromal Lymphopoietin Is Required for Gastrointestinal Allergy but Not Oral Tolerance
Blazquez, Ana Belen
Mayer, Lloyd
Berin, M. Cecilia
[J]. GASTROENTEROLOGY, 2010, 139 (04) : 1301 - 1309
[6] Effectiveness of fevipiprant in reducing exacerbations in patients with severe asthma (LUSTER-1 and LUSTER-2): two phase 3 randomised controlled trials
Brightling, Christopher E.
Gaga, Mina
Inoue, Hiromasa
Li, Jing
Maspero, Jorge
Wenzel, Sally
Maitra, Samopriyo
Lawrence, David
Brockhaus, Florian
Lehmann, Thomas
Brindicci, Caterina
Knorr, Barbara
Bleecker, Eugene R.
[J]. LANCET RESPIRATORY MEDICINE, 2021, 9 (01) : 43 - 56
[7] Busse William W, 2019, Allergol Int, V68, P158, DOI 10.1016/j.alit.2019.01.004
[8] The influence of TSLP on the allergic response
Comeau, M. R.
Ziegler, S. F.
[J]. MUCOSAL IMMUNOLOGY, 2010, 3 (02) : 138 - 147
[9] The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II study in uncontrolled allergic asthma
Erpenbeck, Veit J.
Popov, Todor A.
Miller, David
Weinstein, Steven F.
Spector, Sheldon
Magnusson, Baldur
Osuntokun, Wande
Goldsmith, Paul
Weiss, Markus
Beier, Jutta
[J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2016, 39 : 54 - 63
[10] Prostaglandin D2 pathway upregulation: Relation to asthma severity, control, and TH2 inflammation
Fajt, Merritt L.
Gelhaus, Stacy L.
Freeman, Bruce
Uvalle, Crystal E.
Trudeau, John B.
Holguin, Fernando
Wenzel, Sally E.
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (06) : 1504 - +

← 1 2 3 4 →